Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
Tim Pieters(Ghent University Hospital), Pieter Van Vlierberghe(Ghent University Hospital)
Cited by 7
Related Papers
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
|Leukemia|2017|69
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
|The Journal of Experimental Medicine|2021|19